180 related articles for article (PubMed ID: 32000377)
21. Prognosis impact of posttreatment pelvic MRI in patients treated for stage IB2-IIB cervical cancer with chemoradiation therapy.
Moussilmani T; Knight S; Mancini J; Touboul C; Rodriguez F; Bolze PA; Bendifallah S; Ballester M; Collinet P; Kerbage Y; Ouldamer L; Atrous G; Lavoué V; Dion L; Dabi Y; Raimond E; Graesslin O; Huchon C; Mimouni M; Bricou A; Golfier F; Carcopino X
Eur J Surg Oncol; 2021 May; 47(5):1103-1110. PubMed ID: 33160780
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
[TBL] [Abstract][Full Text] [Related]
23. Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Kim YS; Kim HJ; Lee JW; Kim BG; Bae DS; Huh SJ; Nam JH
J Gynecol Oncol; 2012 Oct; 23(4):226-34. PubMed ID: 23094125
[TBL] [Abstract][Full Text] [Related]
24. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
Alleyne-Mike K; van Wijk L; Hunter A
Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
[TBL] [Abstract][Full Text] [Related]
25. Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma.
Yang J; Shen K; Wang J; Yang J; Cao D
J Gynecol Oncol; 2016 Jul; 27(4):e40. PubMed ID: 27102248
[TBL] [Abstract][Full Text] [Related]
26. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
[TBL] [Abstract][Full Text] [Related]
27. Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting.
Jung PS; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
PLoS One; 2015; 10(7):e0132298. PubMed ID: 26176626
[TBL] [Abstract][Full Text] [Related]
28. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
29. Comparison of neoadjuvant treatments followed by radical surgery or chemoradiation on quality of life in patients with stage IB2-IIA cervical cancer.
Sun Z; Huang B; Liu C; Yang Y; Rao Y; Du Y; Ma Y
Gynecol Oncol; 2020 May; 157(2):536-541. PubMed ID: 32173046
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.
Shimada M; Nagao S; Fujiwara K; Takeshima N; Takizawa K; Shoji T; Sugiyama T; Yamaguchi S; Nishimura R; Kigawa J
Int J Clin Oncol; 2016 Dec; 21(6):1128-1135. PubMed ID: 27380169
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
32. Utilization of Hysterectomy Following Chemoradiation for IB2/IIA2 Cervical Cancer in the National Cancer Data Base.
Haque W; Verma V; Butler EB; Teh BS
Anticancer Res; 2018 May; 38(5):3175-3179. PubMed ID: 29715159
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
[TBL] [Abstract][Full Text] [Related]
34. Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis.
Lu W; Lu C; Yu Z; Gao L
Oncol Lett; 2021 Feb; 21(2):160. PubMed ID: 33552278
[TBL] [Abstract][Full Text] [Related]
35. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141
[TBL] [Abstract][Full Text] [Related]
36. Values of three different preoperative regimens in comprehensive treatment for young patients with stage Ib2 cervical cancer.
Zhao YB; Wang JH; Chen XX; Wu YZ; Wu Q
Asian Pac J Cancer Prev; 2012; 13(4):1487-9. PubMed ID: 22799353
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Neoadjuvant Chemotherapy Combined With Brachytherapy Before Radical Hysterectomy on Stage IB2 and IIA Cervical Cancer: A Retrospective Analysis.
Dang Y; Liu Q; Long L; Luan H; Shi Q; Tuo X; Tuo S; Li Y
Front Oncol; 2021; 11():618612. PubMed ID: 33833985
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Radical Surgery and Radiotherapy for the Treatment of Early-Stage Cervical Carcinoma: A Meta-Analysis.
Wang H; Ni C; Xiao W; Yang T; Sun W
Oncol Res Treat; 2021; 44(4):176-183. PubMed ID: 33706315
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
[TBL] [Abstract][Full Text] [Related]
40. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
